IN2014MU00193A - - Google Patents

Info

Publication number
IN2014MU00193A
IN2014MU00193A IN193MU2014A IN2014MU00193A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A IN 193MU2014 A IN193MU2014 A IN 193MU2014A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A
Authority
IN
India
Prior art keywords
acceptable derivative
pharmaceutical
doripenem
ertapenem
meropenem
Prior art date
Application number
Other languages
English (en)
Inventor
Mahesh Vithalbhai Patel
Sachin Bhagwat
Jaykumar Satwaji Satav
Hemant Narendra Khande
Prashant Ratnakar Joshi
Snehal Rameshwar Palwe
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU2017110457A priority Critical patent/RU2705375C2/ru
Priority to IN193MU2014 priority patent/IN2014MU00193A/en
Priority to NZ728036A priority patent/NZ728036A/en
Priority to BR112017003444-1A priority patent/BR112017003444B1/pt
Priority to AU2015208830A priority patent/AU2015208830A1/en
Priority to US15/323,631 priority patent/US10322116B2/en
Priority to CA2954553A priority patent/CA2954553C/fr
Priority to ES15708275T priority patent/ES2804500T3/es
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2015/050421 priority patent/WO2015110950A1/fr
Priority to EP15708275.1A priority patent/EP3217979B8/fr
Publication of IN2014MU00193A publication Critical patent/IN2014MU00193A/en
Priority to ZA2017/00064A priority patent/ZA201700064B/en
Priority to US15/846,929 priority patent/US20180104224A1/en
Priority to AU2020201956A priority patent/AU2020201956B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN193MU2014 2014-01-21 2015-01-20 IN2014MU00193A (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CA2954553A CA2954553C (fr) 2014-01-21 2015-01-20 Compositions pharmaceutiques comprenant des agents antibacteriens
NZ728036A NZ728036A (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
BR112017003444-1A BR112017003444B1 (pt) 2014-01-21 2015-01-20 Composições farmacêuticas compreendendo ertapenem e um composto de fórmula (i)
AU2015208830A AU2015208830A1 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
US15/323,631 US10322116B2 (en) 2014-01-21 2015-01-20 Pharmaceutical compositions comprising antibacterial agents
RU2017110457A RU2705375C2 (ru) 2014-01-21 2015-01-20 Фармацевтические композиции, содержащие антибактериальные агенты
ES15708275T ES2804500T3 (es) 2014-01-21 2015-01-20 Composiciones farmacéuticas que comprenden agentes antibacterianos
IN193MU2014 IN2014MU00193A (fr) 2014-01-21 2015-01-20
PCT/IB2015/050421 WO2015110950A1 (fr) 2014-01-21 2015-01-20 Compositions pharmaceutiques comprenant des agents antibactériens
EP15708275.1A EP3217979B8 (fr) 2014-01-21 2015-01-20 Compositions pharmaceutiques comprenant des agents antibactériens
ZA2017/00064A ZA201700064B (en) 2014-01-21 2017-01-04 Pharmaceutical compositions comprising antibacterial agents
US15/846,929 US20180104224A1 (en) 2014-01-21 2017-12-19 Pharmaceutical compositions comprising antibacterial agents
AU2020201956A AU2020201956B2 (en) 2014-01-21 2020-03-18 Pharmaceutical compositions comprising antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN193MU2014 IN2014MU00193A (fr) 2014-01-21 2015-01-20

Publications (1)

Publication Number Publication Date
IN2014MU00193A true IN2014MU00193A (fr) 2015-08-28

Family

ID=52629621

Family Applications (1)

Application Number Title Priority Date Filing Date
IN193MU2014 IN2014MU00193A (fr) 2014-01-21 2015-01-20

Country Status (10)

Country Link
US (2) US10322116B2 (fr)
EP (1) EP3217979B8 (fr)
AU (2) AU2015208830A1 (fr)
CA (1) CA2954553C (fr)
ES (1) ES2804500T3 (fr)
IN (1) IN2014MU00193A (fr)
NZ (1) NZ728036A (fr)
RU (1) RU2705375C2 (fr)
WO (1) WO2015110950A1 (fr)
ZA (1) ZA201700064B (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
DK2748165T3 (en) * 2011-08-27 2016-12-19 Wockhardt Ltd 1,6-diazabicyclo [3,2,1] octane-7-ON DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
SG10201605368UA (en) * 2012-05-30 2016-08-30 Meiji Seika Pharma Co Ltd NOVEL β-LACTAMASE INHIBITOR AND PROCESS FOR PREPARING THE SAME
RU2676482C2 (ru) * 2013-01-14 2018-12-29 Вокхардт Лимитед Композиции и способы лечения бактериальных инфекций
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Also Published As

Publication number Publication date
US20180104224A1 (en) 2018-04-19
AU2020201956B2 (en) 2020-07-09
US20170202813A1 (en) 2017-07-20
ZA201700064B (en) 2018-08-29
RU2017110457A3 (fr) 2018-10-03
EP3217979A1 (fr) 2017-09-20
US10322116B2 (en) 2019-06-18
RU2017110457A (ru) 2018-10-03
EP3217979B8 (fr) 2020-06-03
WO2015110950A1 (fr) 2015-07-30
NZ728036A (en) 2019-12-20
RU2705375C2 (ru) 2019-11-07
BR112017003444A2 (pt) 2023-03-07
CA2954553A1 (fr) 2015-07-30
AU2015208830A1 (en) 2017-04-27
EP3217979B1 (fr) 2020-04-08
AU2020201956A1 (en) 2020-04-02
CA2954553C (fr) 2022-12-06
ES2804500T3 (es) 2021-02-08

Similar Documents

Publication Publication Date Title
EP3687543A4 (fr) Agents pharmaceutiques en combinaison en tant qu'inhibiteurs de rsv
GEP20207074B (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
MD20160118A2 (ro) Derivaţi ai pirolidin-2,5-dionei, compoziţii farmaceutice şi metode de utilizare ca inhibitori ai IDO1
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
EP3253382A4 (fr) Compositions pharmaceutiques pour thérapie combinée
EP3280421A4 (fr) Compositions pharmaceutiques pour thérapie combinée
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
EP3417853A4 (fr) Composition pharmaceutique pour le traitement d'un cancer, contenant un composé polyphénol utilisé comme principe actif
MX2018014813A (es) Composiciones antibacterianas.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
EP3946316A4 (fr) Compositions pharmaceutiques de cannabidiol
EP3682016A4 (fr) Formulations pour l'administration de composés
MX2016005160A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
IN2014MU00859A (fr)
IN2013MU03421A (fr)
IN2014MU00193A (fr)
EP4081251A4 (fr) Compositions pharmaceutiques
EP3984549A4 (fr) Composition médicinale
EP3914234A4 (fr) Compositions pharmaceutiques
EP3949952A4 (fr) Composition médicinale
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
EP3650024A4 (fr) Composition pharmaceutique pour administration par voie nasale
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.